Do I need an in-person exam for Wegovy?

Can You Really Get Wegovy, Ozempic, or Mounjaro Online?

The rise of telehealth has revolutionized access to healthcare services, including weight loss treatments. If you’re considering GLP-1 medications like Wegovy (semaglutide) or Mounjaro (tirzepatide) for weight management, you might wonder: ‘Can I legitimately get these prescriptions online?’ The short answer is yes, but with some important qualifications.

GLP-1 weight loss medications are not controlled substances under federal law, meaning they don’t face the same strict telehealth prescribing restrictions as medications like Adderall or opioids. This makes them legally accessible via telehealth in all states, though specific requirements vary by location.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

How Telehealth Weight Loss Prescription Works

When you seek weight loss medication through a reputable telehealth provider like Klarity Health, the process typically follows these steps:

1. Initial consultation: You’ll complete a comprehensive health questionnaire and have a video appointment with a licensed healthcare provider who will evaluate your medical history, current health status, and weight management goals.

2. Medical evaluation: The provider will determine if you meet the clinical criteria for GLP-1 medications—typically a BMI of 30+ (or 27+ with weight-related conditions like hypertension or diabetes).

3. Prescription and follow-up plan: If appropriate, your provider will electronically send a prescription to your pharmacy and establish a follow-up schedule to monitor your progress.

4. Ongoing care: Regular check-ins (usually every 1-3 months) allow your provider to assess your response to the medication, manage any side effects, and adjust your treatment plan as needed.

State-by-State Telehealth Rules for Weight Loss Medications

While federal law permits telehealth prescribing of GLP-1s nationwide, state regulations create a patchwork of additional requirements:

States With Minimal Restrictions

These states allow telehealth prescribing of weight loss medications with no mandatory in-person visits:

• California: Pioneer in telehealth access; providers can prescribe GLP-1s after a video consultation
• New York: Fully embraces telehealth; no in-person requirement for weight management medications
• Illinois: Allows complete telehealth evaluation and prescription for non-controlled substances
• Washington: Progressive telehealth policies with no in-person mandate for weight loss treatments

States With Moderate Requirements

These states have specific protocols for telehealth weight loss prescriptions:

• Florida: Requires BMI documentation and follow-up visits at least once every 3 months
• Texas: While an initial in-person exam is generally expected, many providers now accept telehealth evaluations with proper documentation
• Virginia: Mandates a comprehensive initial evaluation (can be telehealth) with required follow-up within 30 days of starting therapy

States With Stricter Rules

These states typically require at least one in-person visit:

• Arkansas: Must conduct the first exam in-person before transitioning to telehealth
• Georgia: Initial in-person evaluation required before prescribing weight loss medications
• South Carolina: In-person examination required before telehealth weight management therapy
• Mississippi: State law requires an initial in-person visit for weight management prescriptions

Who Can Prescribe GLP-1 Medications via Telehealth?

Understanding who can legally prescribe these medications helps ensure you’re receiving legitimate care:

• MDs and DOs: Medical doctors and osteopathic physicians can prescribe in all states (when licensed in your state)
• Nurse Practitioners (NPs): Can prescribe in all states, but authority varies:
• In states like Washington, California, and New York, NPs have full independent practice authority
• In states like Texas and Florida, NPs require physician oversight agreements
• Physician Assistants (PAs): Similar to NPs, PAs can prescribe with varying levels of physician supervision depending on state laws

Klarity Health ensures all providers meet appropriate state requirements, so your care is always compliant with local regulations.

Common Misconceptions About Online Weight Loss Prescriptions

Myth: ‘Anyone can get Wegovy or Ozempic online regardless of need’

Reality: Legitimate telehealth providers conduct thorough evaluations. You typically need to meet clinical criteria (BMI ≥30 or ≥27 with comorbidities) and have tried lifestyle modifications. Providers should screen for contraindications like pregnancy, history of medullary thyroid cancer, or severe gastrointestinal disorders.

Myth: ‘Online prescriptions are less legitimate than in-person ones’

Reality: A proper telehealth consultation must meet the same standard of care as in-person visits. Reputable providers document medical history, current medications, allergies, and baseline vitals, and they explain potential risks and benefits.

Myth: ‘GLP-1 medications are just quick-fix ‘diet pills”

Reality: Unlike older stimulant appetite suppressants, GLP-1 agonists work through complex mechanisms affecting blood glucose, stomach emptying, and appetite centers in the brain. They require ongoing monitoring, gradual dose titration, and lifestyle changes for optimal results.

Red Flags When Seeking Online Weight Loss Treatment

Be wary of telehealth services that:

• Guarantee prescriptions without thorough evaluation
• Offer ‘compounded’ versions of semaglutide (FDA banned most compounded GLP-1s in 2025)
• Don’t require video consultations with licensed providers
• Skip discussions about risks, side effects, and alternatives
• Fail to schedule regular follow-ups to monitor your progress
• Lack transparency about provider credentials or state licensure

Best Practices for Safe Telehealth Weight Loss Treatment

When seeking GLP-1 medications through telehealth, ensure you:

1. Choose established providers: Select platforms like Klarity Health that have licensed providers in your state and transparent practices.

2. Be completely honest: Provide accurate health information during your consultation, as undisclosed conditions could affect your safety.

3. Understand the commitment: GLP-1 treatments typically require regular injections, potential side effects (mostly gastrointestinal), and lifestyle modifications.

4. Plan for follow-up care: Expect regular check-ins to monitor progress, possibly including lab work to ensure safety.

5. Check insurance coverage: While telehealth consultations are often affordable, the medications themselves can be expensive without insurance coverage.

Looking Forward: Telehealth Regulations in 2026

The telehealth landscape continues to evolve:

• The DEA’s COVID-era telehealth flexibilities for controlled substances remain in effect through December 31, 2025, but these don’t directly affect GLP-1 medications
• More states are expanding nurse practitioner authority, potentially increasing provider availability
• Insurance coverage for GLP-1 weight loss medications is gradually improving, though still variable
• New anti-obesity medications are in development, which may further expand telehealth options

Take the Next Step with Klarity Health

If you’re considering GLP-1 weight loss treatment, Klarity Health offers convenient, compliant telehealth access to qualified providers who understand the nuances of state regulations. Our platform provides:

• Appointments with licensed providers in your state
• Transparent pricing with both insurance and cash-pay options
• Comprehensive evaluations that meet medical standards
• Ongoing support throughout your weight management journey
• Regular provider availability for follow-up care

Weight loss is a personal journey, and modern telehealth options make it more accessible than ever to receive medically-supervised treatment. With the right provider and commitment to the process, GLP-1 medications can be a valuable tool in your weight management toolbox.

Ready to explore whether GLP-1 medications might be right for you? Schedule a consultation with Klarity Health today to discuss your options with a licensed provider who understands your state’s requirements.

Citations

1. DEA and HHS. ‘DEA and HHS Extend Telemedicine Flexibilities through 2025.’ DEA.gov. November 15, 2024.

2. Axios News. ‘COVID-era telehealth prescribing extended through 2025.’ Axios.com. November 18, 2024.

3. Goodwin Procter LLP. ‘Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs.’ GoodwinLaw.com. March 27, 2024.

4. Reuters News. ‘Hims cut 4% workforce amid ban on weight-loss drug copies.’ Reuters.com. May 30, 2025.

5. Nextech. ‘Know Your State’s Laws Around Semaglutide.’ Nextech.com. April 11, 2025.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid